Deslorelin

Deslorelin

Clinical data
Trade names	Ovuplant
AHFS/Drugs.com	International Drug Names
Pregnancy category	X (USA)
Routes of administration	implant / Inhalation
ATCvet code	Template:Infobox drug/formatATCvet Template:Infobox drug/formatATCvet
Pharmacokinetic data
Excretion	renal
Identifiers
IUPAC name (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
CAS Number	57773-65-6 N
PubChem CID	25074999
UNII	TKG3I66TVE
ChEMBL	ChEMBL2365665 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C64H83N17O12
Molar mass	1282.45 g/mol
3D model (JSmol)	Interactive image
SMILES CCNC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC3=C[N]C=N3)NC(=O)C4CCC(=O)N4)CC5=C[N]C6=C5C=CC=C6)CC7=C[N]C8=C7C=CC=C8
NY (what is this?)  (verify)

WikiDoc Resources for Deslorelin
Articles
Most recent articles on Deslorelin Most cited articles on Deslorelin Review articles on Deslorelin Articles on Deslorelin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Deslorelin Images of Deslorelin Photos of Deslorelin Podcasts & MP3s on Deslorelin Videos on Deslorelin
Evidence Based Medicine
Cochrane Collaboration on Deslorelin Bandolier on Deslorelin TRIP on Deslorelin
Clinical Trials
Ongoing Trials on Deslorelin at Clinical Trials.gov Trial results on Deslorelin Clinical Trials on Deslorelin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Deslorelin NICE Guidance on Deslorelin NHS PRODIGY Guidance FDA on Deslorelin CDC on Deslorelin
Books
Books on Deslorelin
News
Deslorelin in the news Be alerted to news on Deslorelin News trends on Deslorelin
Commentary
Blogs on Deslorelin
Definitions
Definitions of Deslorelin
Patient Resources / Community
Patient resources on Deslorelin Discussion groups on Deslorelin Patient Handouts on Deslorelin Directions to Hospitals Treating Deslorelin Risk calculators and risk factors for Deslorelin
Healthcare Provider Resources
Symptoms of Deslorelin Causes & Risk Factors for Deslorelin Diagnostic studies for Deslorelin Treatment of Deslorelin
Continuing Medical Education (CME)
CME Programs on Deslorelin
International
Deslorelin en Espanol Deslorelin en Francais
Business
Deslorelin in the Marketplace Patents on Deslorelin
Experimental / Informatics
List of terms related to Deslorelin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Deslorelin acetate is an injectable gonadotropin releasing hormone super-agonist (GnRH agonist) also known as an LHRH agonist. It stops the production of sex hormones (testosterone and oestrogen).

Deslorelin Acetate is marketed by Peptech with the brand name Ovuplant. It is currently approved for use in veterinary medicine and is used to induce ovulation in mares as part of the artificial insemination process. It is also used to stabilize high-risk pregnancies, mainly of livestock. Unlike other GnRH agonists, which are mainly used to inhibit luteinizing hormone and follicle-stimulating hormone by their ultimate downregulation of the pituitary gland, Deslorelin is primarily used for the initial flare effect upon the pituitary, and its associated surge of LH secretion.

Pharmacokinetics

Deslorelin is a synthetic analogue of a naturally occurring luteinising-hormone releasing hormone (LHRH). Bioavailability is almost complete.

Clinical trials

Deslorelin was successfully trialed in the US and was approved for veterinary use under certain circumstances. In Europe, it was approved for use in equine assisted reproduction.

It is also being trialed in humans to study its efficacy in treatment of breast cancer in women, and in treating precocious puberty and congenital adrenal hyperplasia in male and female children.

As of August 2011 this drug was not approved for general use in the US, other than within approved clinical trials. Orphan drug status has been designated in the US, though approval had not been issued as of 2011.